Search Results - "Telli, M."

Effects of green light supplementation with red and blue combinations of LED light spectrums on the growth and transcriptional response of Haematococcus pluvialis by Karagülle, G., Telli, M.

“…Light management strategy is crucial for improving microalgal production in terms of higher biomass and economically valuable bioactive molecules. However,…”
Get full text

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate by Telli, M.L., Witteles, R.M., Fisher, G.A., Srinivas, S.

“…In the pivotal phase III metastatic renal cell carcinoma trial, updated data indicates that 21% of sunitinib-treated patients experienced a decline in left…”
Get full text

Soda Lime Silicate Glass Tube-Titanium Inset Joining by O 2 /Propane Flame Work in Air by Telli, M.

Get full text

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study by Han, H.S., Diéras, V., Robson, M., Palácová, M., Marcom, P.K., Jager, A., Bondarenko, I., Citrin, D., Campone, M., Telli, M.L., Domchek, S.M., Friedlander, M., Kaufman, B., Garber, J.E., Shparyk, Y., Chmielowska, E., Jakobsen, E.H., Kaklamani, V., Gradishar, W., Ratajczak, C.K., Nickner, C., Qin, Q., Qian, J., Shepherd, S.P., Isakoff, S.J., Puhalla, S.

“…Homologous recombination defects in BRCA1/2-mutated tumors result in sensitivity to poly(ADP-ribose) polymerase inhibitors, which interfere with DNA damage…”
Get full text

Future of checkpoint blockade in triple-negative breast cancer: combination strategies to lead the way by Telli, M.L., Vinayak, S.

Get full text

Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer by Telli, M. L., Stover, D. G., Loi, S., Aparicio, S., Carey, L. A., Domchek, S. M., Newman, L., Sledge, G. W., Winer, E. P.

“…Purpose Triple-negative breast cancer (TNBC) is associated with worse outcomes relative to other breast cancer subtypes. Chemotherapy remains the…”
Get full text

MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species by Marí-Almirall, M., Cosgaya, C., Higgins, P.G., Van Assche, A., Telli, M., Huys, G., Lievens, B., Seifert, H., Dijkshoorn, L., Roca, I., Vila, Jordi

“…Rapid identification of Acinetobacter species is critical as members of the A. baumannii (Ab) group differ in antibiotic susceptibility and clinical outcomes…”
Get full text

Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands by Schoeb, Manuela, Avci, Telli M., Winter, Elizabeth M., Appelman‐Dijkstra, Natasha M.

“…ABSTRACT Impact microindentation (IMI) is a technique to assess bone material properties of the cortical bone at the tibia in a transcutaneous, microinvasive,…”
Get full text

Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial by Hurvitz, S.A., Quek, R.G.W., Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E., Mina, L.A., Balmaña, J., Fasching, P.A., Bhattacharyya, H., Hannah, A.L., Robson, M.E., Wardley, A.M.

“…Talazoparib (1 mg/day) exhibited promising efficacy and safety in patients with advanced breast cancer during ABRAZO (NCT02034916); this study evaluated…”
Get full text

Joining of Soda Lime Silicate Glass to Dissimilar Ti-304L Metal Joint by Heat Treatment in Air by Telli, M., Sanl i, H.

Get full text

Titanium-304L Stainless Steel Joining by Powder Metallurgical Uniaxial Pressing under Vacuum Conditions by Telli, M., Yamanoglu, R., Sanlı, H.

Get full text

Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC) by Meric-Bernstam, F, Tannir, N, Harding, J, Voss, M, Mier, J, DeMichele, A, Munster, P, Patel, M, Iliopoulos, O, Owonikoko, T, Whiting, S, Orford, K, Bennett, M, Carvajal, R, McKay, R, Fan, A, Telli, M, Infante, J

“…Background: CB-839 is a first-in-class highly selective inhibitor of glutaminase (GLS), a key enzyme in the utilization of glutamine by many cancer types…”
Get full text

1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC) by Bardia, A, Cameron, J.S, Venkatesan, K, Robinson, D, Porter, D, Kim, S.B, Parton, M, Kümmel, S, Estevez, L.G, Huang, C.S, Cortes Castan, J, Ruiz-Borrego, M, Telli, M, Martín Martorell, P, Lopez, R, Beck, J.T, Ismail-Khan, R, Chen, S.C, Hurvitz, S, Mayer, I

Get full text

Abstract MS1-2: New clinical approaches for TNBC by Telli, M

“…Abstract Over the last decade, triple-negative breast cancer (TNBC) has been the subject of intense clinical investigation. Importantly, an improved…”
Get full text

5025 POSTER DISCUSSION Phase 3 Study of Iniparib (I) Plus Gemcitabine (G) and Carboplatin (C) in Metastatic Triple-negative Breast Cancer (mTNBC) – Results of an Exploratory Analysis by Prior Therapy by O'Shauqhnessv, J, Telli, M, Swain, S, Gralow, J, Rugo, H, Litton, J, Charpentier, E, Smith, J, Blackwood-Chirchir, A, Winer, E

Get full text

Antimicrobial Resistance in Gram-Negative Hospital Isolates: Results of the Turkish HITIT-2 Surveillance Study of 2007 by Gur, D., Hascelik, G., Aydin, N., Telli, M., Gültekin, M., Ögünç, D., Arikan, O.A., Uysal, S., Yaman, A., Kibar, F., Gülay, Z., Sumerkan, B., Esel, D., Kayacan, C.B., Aktas, Z., Soyletir, G., Altinkanat, G., Durupinar, B., Darka, O., Akgün, Y., Yayla, B., Gedikoglu, S., Sinirtas, M., Berktas, M., Yaman, G.

“…Resistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/sulbactam and piperacillin/tazobactam in Escherichia coli (n=…”
Get full text

Egg production and growth rates of Calanus euxinus (Copepoda) in the Black Sea by Besiktepe, S., Telli, M.

“…Egg production rates (EPRs) of Calanus euxinus were measured in the Black Sea during October 2000 and May 2001. EPRs were generally low, on average 1.7 eggs…”
Get full text

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer by Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.

“…In the phase III IMpassion130 trial, combining atezolizumab with first-line nanoparticle albumin-bound-paclitaxel for advanced triple-negative breast cancer…”
Get full text

Soda Lime Silicate Glass-to-Titanium Joining by Controlled Heat Treatments in Air by Telli, M.B.

Get full text

Soda Lime Silicate Glass-Copper Metal Joining by Controlled Heat Treatments in Air by Telli, M.B.

Get full text